Vifor Pharma
VIFN.SW
$179.34
Share price
0.48%
Change (1 day)
0.59%
Change (1 year)
Categories
Revenue for Vifor Pharma (VIFN.SW)
Revenue in 2021: $1.99 B
According to Vifor Pharma's latest financial reports the company's current revenue (TTM) is $1.99 B. In 2021 the company made a revenue of $1.99 B an increase over the years 2020 revenue that were of $1.93 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Vifor Pharma from 2002 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 | $1.99 B | 3.22% |
| 2020 | $1.93 B | -0.18% |
| 2019 | $1.93 B | 20.3% |
| 2018 | $1.61 B | 16.89% |
| 2017 | $1.37 B | -65.91% |
| 2016 | $4.04 B | 5.35% |
| 2015 | $3.83 B | 11.05% |
| 2014 | $3.45 B | -8.73% |
| 2013 | $3.78 B | 4.9% |
| 2012 | $3.60 B | 6.24% |
| 2011 | $3.39 B | 2.28% |
| 2010 | $3.32 B | 4.77% |
| 2009 | $3.17 B | 5.7% |
| 2008 | $2.99 B | 34.26% |
| 2007 | $2.23 B | 26.29% |
| 2006 | $1.76 B | 11.44% |
| 2005 | $1.58 B | -10.43% |
| 2004 | $1.77 B | -18.91% |
| 2003 | $2.18 B | -14.82% |
| 2002 | $2.56 B |